NT5E and heart failure: To determine whether IL‐1ß could exert similar effects on human cells, cMSCs from cardiac biopsies of patients with advanced heart failure, characterized by expression of CD73, CD29 and CD140a (Figure S5a), were treated in vitro by IL‐1ß.